[Bisphosphonates in the treatment of breast carcinoma].
Stajszczyk
M
M
Klinika Chorób Wewnetrznych i Chemioterapii Onkologicznej Sl. AM w Katowice. marcins(at)mp.pl
Mykała-Cieśla
J
J
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology*; D004002:Clodronic Acid / Q000627:therapeutic use; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D000077268:Pamidronate; D000077211:Zoledronic Acid
D000970:Antineoplastic Agents; D004164:Diphosphonates; D007093:Imidazoles; D004002:Clodronic Acid; D000077211:Zoledronic Acid; D000077268:Pamidronate
Bifosfoniany w leczeniu raka piersi.